SPAC & De-SPAC Valuation · United States

SPAC and De-SPAC Valuation Services

Independent, audit-ready valuations at every stage of the SPAC lifecycle, from IPO through de-SPAC and beyond. Led by CVA.
Get a Quote
SPAC and de-SPAC valuation analysis with financial models and SEC-compliant reports
SPAC & De-SPAC Valuation
Special purpose acquisition companies remain one of the most active channels for taking private businesses public in the United States. In 2025, SPACs accounted for approximately 40 percent of US IPO deal count, and early 2026 data confirms this momentum is holding. Yet every SPAC transaction, from the initial public offering through the de-SPAC merger and well into post-combination reporting, generates a series of complex valuation requirements that carry regulatory, financial-reporting, and litigation risk if handled poorly. Equirium Analytics provides independent, CVA-led SPAC and de-SPAC valuation services that cover the full lifecycle: sponsor promote and warrant valuations at formation, fairness opinions and target enterprise valuations at the deal stage, and purchase price allocation, earnout remeasurement, and ongoing fair-value reporting after the merger closes.

Why SPAC and De-SPAC Transactions Require Specialist Valuation ?

A single SPAC transaction can involve a dozen or more distinct financial instruments, each with its own classification, measurement basis, and reporting trigger. Warrants may require liability classification under ASC 815. Earnout shares introduce contingent consideration that must be remeasured to fair value every reporting period. Purchase price allocation demands identification and measurement of intangible assets under ASC 805. A generalist approach to any of these creates exposure.

The Regulatory Landscape After SEC's 2024 Final Rules

The SEC's final rules adopted in July 2024 imposed significant additional disclosure and procedural requirements on both SPAC IPOs and de-SPAC business combinations. These rules mandate enhanced disclosure around sponsor conflicts of interest, shareholder dilution analysis, and the treatment of financial projections in SEC filings. The rules also clarified the potential liability of participants acting as underwriters in de-SPAC transactions. For valuation professionals, the practical effect is clear: every fair-value conclusion now faces greater regulatory scrutiny, and the documentation supporting those conclusions must be more rigorous than ever.

What Happens When Valuations Go Wrong ?

Warrant reclassification from equity to liability is one of the most common valuation-related restatement triggers in SPAC transactions. When public or private placement warrants are initially classified as equity but later determined to meet the criteria for liability treatment under ASC 815, the resulting restatement requires retroactive fair-value remeasurement, restated financial statements, and potential SEC comment letters. Earnout miscalculations and flawed purchase price allocations create similar cascading effects, from auditor qualification to shareholder litigation. Early coordination between the sponsor, the target company, legal counsel, the auditor, and the valuation specialist is the single most effective way to eliminate restatement risk.

SPAC Lifecycle

What We Value Across the SPAC Lifecycle ?

SPAC valuation is not a single engagement. It is a series of interconnected analyses that correspond to specific stages in the transaction lifecycle. The instruments that require valuation, the standards that govern them, and the intended users of the reports differ at each stage.

Get a Quote

  • Pre-IPO and IPO Stages

     Before the SPAC goes public, sponsors structure the equity and warrant economics that define their returns. This stage typically requires fair-value measurement of the sponsor promote (founder), public warrants, private placement warrants, rights, and units. The initial fair-value measurement at this stage sets the baseline for all subsequent reporting and determines classification (equity versus liability) for each instrument.

  • De-SPAC Transaction Stage.

     The de-SPAC merger is where the highest concentration of valuation work occurs. The target company's enterprise value must be determined through a rigorous analysis that accounts for redemption scenarios, PIPE dilution, and the specific terms of the merger consideration. This is also the stage where fairness opinions are typically delivered to the board or special committee of the SPAC, confirming that the transaction consideration is fair from a financial point of view. PIPE securities, if part of the deal structure, require separate valuation to support pricing and allocation.

  • Post-Merger Financial Reporting.

     After the de-SPAC closes, the combined entity faces a new set of reporting obligations. Purchase price allocation under ASC 805 requires identification and fair-value measurement of all acquired tangible and intangible assets, assumed liabilities, and any resulting goodwill or bargain purchase gain. Warrants that were classified as liabilities must be remeasured to fair value at each reporting date under ASC 815 and ASC 820. Earnout and contingent consideration arrangements require ongoing fair-value remeasurement until they vest, settle, or expire. Share-based compensation issued in connection with the transaction must be measured under ASC 718, and cheap-stock considerations may apply to equity grants made in periods preceding the de-SPAC.
Methodology

Our Methodology

Equirium Analytics applies valuation methodologies that are consistent with NACVA professional standards, the ASC framework, and accepted practices for SEC-filed reports. Every methodology selection is documented, justified, and defensible under audit review.

Enterprise and Equity Valuation

For target company enterprise value, we apply the income approach (discounted cash flow using free cash flow to the firm or free cash flow to equity), the market approach (guideline public company method and guideline transaction method), and, where appropriate, a backsolve method anchored to observable transaction data. Redemption rate scenarios and PIPE dilution are modelled explicitly to reflect the range of possible post-closing capital structures.

Complex Securities and Derivative Instruments

Warrants, earnouts, and other contingent instruments require option-pricing models calibrated to the specific terms and conditions of the instrument. We use Black-Scholes, binomial lattice, and Monte Carlo simulation models depending on the complexity of the payoff structure. For warrants, the analysis includes a detailed classification assessment under ASC 815 to determine whether the instrument meets the criteria for equity classification or must be treated as a derivative liability measured at fair value.

Purchase Price Allocation Under ASC 805

Purchase price allocation requires a systematic process for identifying all acquired assets and assumed liabilities, including intangible assets that may not appear on the target's pre-acquisition balance sheet. We identify and measure customer relationships, developed technology, trade names, non-compete agreements, and other intangible assets using the income approach (multi-period excess earnings, relief from royalty) and the cost approach. Goodwill is measured as the residual after all identifiable assets and liabilities are recorded at fair value. We coordinate directly with the engagement auditor throughout the allocation process to streamline review and approval.

Who We Serve ?

01

SPAC Sponsors and Management Teams

Sponsors need independent valuation support from the earliest stages of SPAC formation. We provide fair-value measurement of promote economics and warrant structures at IPO, target screening valuation support during the acquisition search, and the full suite of de-SPAC valuations through closing and beyond. Our independence from sponsor economics ensures every conclusion is defensible under regulatory and shareholder scrutiny.

02

Target Companies and Their Boards

For target companies evaluating a SPAC merger as their path to the public markets, we deliver enterprise valuation support for deal negotiation, fairness opinions for the board or special committee, and post-merger valuation services including purchase price allocation and ongoing financial reporting. Our reports are structured for SEC filings and auditor review from the outset, reducing the risk of comment letters and restatements.

03

Investors, PIPEs, and Legal Counsel

Institutional investors, PIPE participants, and legal counsel rely on independent valuation to support investment decisions, validate pricing, and manage litigation risk. We provide PIPE pricing validation, independent enterprise valuation for investment committee review, and expert valuation support for disputes and litigation arising from SPAC transactions.

Why Equirium Analytics ?

CVA-led US Practice.
Every engagement is led by Harsh, a NACVA Certified Valuation Analyst with experience delivering compliant valuations across US engagements. The CVA credential is an authorized basis for US business-valuation reports.

Independence.
Equirium Analytics has no advisory, sponsorship, or principal-investment interest in SPAC transactions. Our conclusions are free from conflicts of interest, which is exactly what regulators, auditors, and shareholders expect.

Audit-ready Deliverables.
Our reports are structured and documented to meet the requirements of SEC filings, Big Four and mid-tier auditor review, and shareholder scrutiny. We anticipate audit questions and address them in the report, not after it.

NDA-first, Data-secure Process.
Confidentiality agreements are executed before any information is exchanged. Sensitive financial data, projections, and deal terms are handled with strict data-security protocols throughout the engagement.

Why businesses choose Equirium Analytics for valuation
Our Process

How We Work ?

Equirium follows a structured, six-step process designed for the compressed timelines and multi-party coordination that SPAC transactions demand.

Consultation and Scoping

We define the instruments, standards, and deliverables required at your specific stage of the SPAC lifecycle.

Information Gathering

Financial statements, projections, deal terms, warrant agreements, and capital structure details are collected through a secure, structured process.

Analysis and Modelling

Enterprise valuation, instrument-level fair-value measurement, and classification analysis are performed using the methodologies appropriate to each instrument and reporting standard.

Draft Report and Review

A comprehensive draft report is delivered for your review and, where applicable, for preliminary auditor discussion before finalization.

Final Deliverables

Finalized valuation reports, fairness opinions, and supporting schedules are delivered in SEC-filing-ready and audit-ready format.

Ongoing Support

Periodic remeasurement of warrants, earnouts, and other instruments is provided as required by the reporting calendar. We also support responses to SEC comment letters related to valuation.

Frequently Asked Questions

1What valuations are required in a de-SPAC transaction?
A de-SPAC transaction typically requires an enterprise valuation of the target company, a fairness opinion for the SPAC's board or special committee, fair-value measurement of public and private warrants (for liability classification under ASC 815), valuation of PIPE securities if applicable, and purchase price allocation under ASC 805 after closing. Earnout and contingent consideration arrangements require separate fair-value measurement at inception and at each subsequent reporting period.
2How are SPAC warrants valued for financial reporting?
SPAC warrants are typically valued using option-pricing models such as Black-Scholes, binomial lattice, or Monte Carlo simulation, depending on the complexity of the warrant terms. Public warrants with observable market prices may use a market-based approach. Private placement warrants, which often have features (such as non-transferability or cashless exercise provisions) that differ from public warrants, require model-based valuation. Warrants classified as liabilities under ASC 815 must be remeasured to fair value at each reporting date, with changes recognized in earnings.
3When is a fairness opinion needed in a SPAC merger?
A fairness opinion is typically obtained by the SPAC's board of directors or a special committee to support their fiduciary obligations when approving a de-SPAC business combination. It provides an independent assessment of whether the merger consideration is fair from a financial point of view to the SPAC's shareholders. While not always legally required, a fairness opinion is considered best practice and provides important protection in the event of shareholder challenges or litigation.
4What is purchase price allocation after a de-SPAC?
Purchase price allocation (PPA) is the process of assigning the total consideration paid in the de-SPAC transaction to the acquired company's identifiable tangible and intangible assets and assumed liabilities at their fair values, with any excess recorded as goodwill. This is required under ASC 805 (Business Combinations) and must be completed for the combined entity's first post-merger financial statements. Common intangible assets identified in SPAC PPAs include customer relationships, developed technology, trade names, and non-compete agreements.
5How long does a SPAC valuation engagement typically take?
Timeline depends on the scope and stage. A single-instrument valuation (such as a warrant remeasurement) can be completed in one to two weeks. A full de-SPAC engagement covering enterprise valuation, fairness opinion, and post-merger purchase price allocation typically runs four to eight weeks, depending on the complexity of the target, the number of instruments involved, and the responsiveness of the data-gathering process. We structure engagements to align with SEC filing deadlines and auditor review schedules.
6Does Equirium Analytics support SEC comment letter responses?
Yes. SEC comment letters frequently raise questions about the valuation methodologies, assumptions, and classifications used in SPAC and de-SPAC filings. We provide direct support in drafting responses to valuation-related SEC comments, including additional documentation, sensitivity analyses, and clarifications of the methodologies applied. This support is available as part of the ongoing engagement or as a standalone service.
7Can Equirium handle both pre-merger and post-merger valuation needs?
Equirium Analytics is structured to support SPAC valuation requirements across the entire lifecycle. From sponsor promote and warrant valuations at formation, through enterprise valuation and fairness opinions at the deal stage, to purchase price allocation and periodic remeasurement after closing, a single team maintains continuity across every phase. This reduces onboarding time, eliminates knowledge gaps between engagement stages, and ensures methodological consistency throughout.

Bring us the decision.
We'll build the number that holds.

  • CVA Led Team
  • Independent and NDA-first.
  • Transaction-ready delivery.
  • Specialists in securities valuation.